A veteran in the Midwest who wants something beyond the antidepressants that did not work will find three kinds of places offering "ketamine care." A certified clinic that gives an FDA-approved nasal spray under observation. An infusion center that runs IV drips. And a telehealth company that mails lozenges to your door. The signs and websites can look alike. What happens inside is not alike at all.

This comparison puts the three side by side, with a fourth option, the hybrid, layered on top. It draws on a summer survey, funded by our publisher, covering 443 adults in ten Midwest states. Those who answered were ordinary members of the public rather than a veterans' group, and every figure below is a whole-sample number from the final validated data.

What people said about setting

Given a choice of how to receive a newer treatment like ketamine or esketamine, the most popular answer was a nearby clinic, picked by 44 percent. Home telehealth and a clinic-first, home-later arrangement came next, at 22 and 23 percent respectively. Eleven percent did not mind either way.

Combine clinic and hybrid answers and 67 percent wanted a clinic at some point in their care. As you will see, only one of the three places below offers the one FDA-approved option in this family, and it is a clinic.

Place 1: The certified esketamine clinic

What it offers. Spravato, which is esketamine in a nose spray. It has FDA approval for grown-ups whose depression standard antidepressants have not relieved, and, combined with an antidepressant taken by mouth, for grown-ups facing a major depressive episode with acute suicidal thoughts or behavior. Its label says nothing about PTSD.

Oversight. The strongest of the three. Doses are given on site, and a clinician watches you for a period afterward since dissociation, sedation, and blood pressure spikes can occur.

Time and travel. The toughest. Each visit eats a couple of hours, driving is off until the next day, and early treatment usually means more frequent visits. Rural veterans may face a long round trip with a driver.

Cost. Frequently covered with prior authorization by TRICARE, Medicare, Medicaid, and commercial plans, depending on the plan and your history.

Good fit if: a psychiatrist has evaluated you and recommends it, and you can arrange rides. Brain Recovery Centers has a page describing Spravato care.

Place 2: The IV infusion center

What it offers. Generic ketamine by intravenous drip. Its approval is for anesthesia, so using it for depression is an off-label choice the clinician makes.

Oversight. Good during the infusion itself, since you are in a chair with staff nearby. Screening and follow-up vary by center.

Time and travel. Similar to the esketamine clinic, with a ride required afterward.

Cost. Usually self-pay, because off-label infusions for depression are rarely covered.

Good fit if: your own clinician has weighed it against approved options and you understand you are paying for an off-label use.

Place 3: The telehealth company

What it offers. A video intake, then ketamine lozenges or tablets shipped to your home and taken without a clinician present. Off-label.

Oversight. The weakest. Some companies screen and follow up carefully. Others do little beyond a questionnaire. The FDA has warned about risks when ketamine is used outside medical supervision.

Time and travel. The easiest by far.

Cost. Almost always out of pocket.

Good fit if: honestly, this is the option to bring to your own doctor before you sign anything. Ask how it would interact with your medications, blood pressure, and any history of head injury or substance use.

The hybrid overlay

A hybrid is not a fourth kind of business. It is a way of combining the others with ordinary telehealth. You might be evaluated in person, receive supervised treatment at a certified clinic, and then handle therapy and medication check-ins by video. For veterans who live far from a city, it can cut the number of trips without cutting supervision where it counts.

Ask any practice that offers a hybrid to put in writing which visits are in person, which are by video, and what happens if you miss one. A clear answer is a good sign the plan was built around real patients rather than a brochure.

The three places at a glance

How the public weighed it

Coverage beat every other consideration by a wide margin. When respondents picked their two leading provider factors, insurance made the list for 85 percent. Being close by was next, at 43 percent. FDA approval claimed the next rung at 27 percent, quick results sat just under it at 24 percent, and 10 percent wanted someone focused on veterans and responders.

Approval mattered in its own right, too. For 59 percent of respondents, FDA approval was either the decider or a major factor. And when offered covered care with extra steps versus cash care with fewer, respondents chose the covered path more than twice as often, 51 percent against 23 percent, with 26 percent unsure.

Where to begin

Almost always with a doctor who knows you. For 56 percent of respondents the first stop was primary care, and 74 percent said the push that would actually get them to try something new would come from their own doctor. Veterans and others followed online moved 4 percent.

This comparison is general guidance, not medical advice, and no option on it is certain to help. The right place, if any, is a decision for a clinician who has evaluated you.

If you are in crisis, or worried about a veteran who is, skip the comparison shopping and pick up the phone: 988, by call or text, with 1 for veterans once connected. Someone answers at every hour.

Methodology

This is a publisher-commissioned study, paid for by the publisher and run through the Pollfish consumer panel. The field period ended June 23, 2026 with n=443 respondents, adults 18 to 64 across Ohio, Indiana, Illinois, Missouri, Iowa, Minnesota, Wisconsin, Kansas, Nebraska, and Oklahoma. Veterans were a small part of a general sample, too small for their own figures, so only whole-sample numbers are reported, all final and validated.